Machvision's board has approved a NT$274 million (US$8.6 million) strategic investment to acquire 13% of Hye Technology's common shares. The investment will represent 11.5% of Hye's...
Donald Trump's potential return as the US President has captured global attention. Peter Chen, chairperson of Qisda, notes that from an economic and industrial perspective, Trump's...
Simula Technology, a subsidiary of Qisda Group, is working to grow the proportion of its Made in Taiwan (MIT) products due to tariffs and clients' demands in the fourth quarter, after...
At Qisda's earnings call on August 7, Chairman and CEO Peter Chen announced that the company expects revenue and profits to rise quarterly in 2024. While the first half of the year...
The Biomedical Technology and Device Research Laboratories (BTDRL) of the Industrial Technology Research Institute (ITRI) has announced a strategic partnership agreement with major...
Qisda is expanding its plans for AI and robots, with chairman Peter Chen noting that the tide has come at just the right time since new talent in Taiwan has been increasingly leaning...
Peter Chen, Chairperson of Qisda, stated that the company has passed the lowest ebb of operation in 2024, with growth expected to occur quarter by quarter.
The most unexpected development in Qisda's history occurred in 2005, when the company's predecessor, BenQ, failed to merge with Siemens Mobile. It made a large loss of NT$30 billion...
A recent article by the Financial Times (FT) reported that several prominent Taiwanese companies are considering establishing a second headquarters abroad to ensure...
MetaAge, a member firm of Taiwan's Qisda Group, has revealed a two-pronged merger and acquisition (M&A) approach, emphasizing domestic core business optimization and expansion...
Qisda's strongest growth momentum comes from its healthcare business as revenue from the sector is expected to surpass NT$30 billion (US$947.75 million).
Qisda Chairperson Peter Chen announced that the group will be picking up its merger and acquisition pace this year, as several of its subsidiaries are slated for IPO and the conglomerate...
The Qisda Group is actively expanding its healthcare business, with revenue from the sector surpassing NT$20 billion (US$638.29 million) in 2023. Given the potential for the healthcare...
